definiens: means, other than Other Bendamustine Products, ( i ) Compounds,(ii ) Products and/or ( iii ) any other compounds or products that are clinically developed specifically for thetreatment or prevention of one or more oncologic diseases that have a Binding Affinity of less than 100nanomolar for one or more of the Buyer Targets ; but, excluding any such compound or product that(a ) has as its most potent Binding Affinity ( which Binding Affinity must be less than 100 nanomolar ), aBinding Affinity for any protein kinase that is not a Buyer Target, and ( b ) has a Binding Affinity for anyBuyer Target that is at least 10 times weaker than such Binding Affinity for such non - Buyer Target ( e.g., ifIC50 for the non - Buyer Target is 10 nanomolar, then IC50 for any Buyer Target must be 101 nanomolaror higher )